Virtual ISPOR Europe 2021 Plenaries and Speakers Announced

Published Nov 17, 2021

Conference Scheduled for 30 November – 3 December

ISPOR Europe 2021Lawrenceville, NJ, USA—November 17, 2021—ISPORThe Professional Society for Health Economics and Outcomes Research (HEOR) announced its plenary speakers for Virtual ISPOR Europe 2021. The conference is centered on the theme “Emerging Frontiers and Opportunities: Special Populations and Technologies” and offers educational and networking opportunities for attendees.

Virtual ISPOR Europe 2021
30 November – 3 December 2021
Virtual ISPOR Europe 2021 will be held 30 November – 3 December with the conference theme, “Emerging Frontiers and Opportunities: Special Populations and Technologies.” Plenary sessions for the virtual conference include:

Plenary 1: Joint HTA Dialogue for Specialized Therapies- Tower of Babel or Lingua Franca?
Tuesday, 30 November 2021
This opening plenary session will discuss the usefulness and gaps of regulatory evidence pathways used for health technology assessment and the potential for a more unified approach to the use of alternative evidence (ie, non-randomized controlled trial data). Speakers include:

  • Moderator: Guido Rasi, MD; Rome University Tor Vergata, Gemelli Polyclinic; Rome, Italy
  • Luciana Ballini, BSc Soc, MSc; Agenzia Sanitaria e Sociale Regionale-Emilia Romagna; Bologna, Italy
  • Jo De Cock, MS; Institut National de l'Assurance Maladie-Invalidité; Brussels, Belgium
  • Hans-Georg Eichler, MD, MSc; Association of Austrian Social Insurance Institutions, Vienna, Austria
  • Rui Santos Ivo; INFARMED; Lisbon, Portugal

Plenary 2: Lessons Learned from EU Collaboration Efforts During the Pandemic - The End or the Beginning? From Vaccines to Orphans and Gene Therapies
Wednesday, 1 December 2021
This plenary session will explore international partnership and dialogue aimed at special populations and technologies that have important implications for a range of European healthcare decisions, including regulatory pathways, pricing and reimbursement, and managed entry agreements. Speakers include:

  • Moderator: Marcin Czech, PhD, MD, MBA; The Institute of Mother and Child, Warsaw University of Technology; Warsaw, Poland
  • Lieven Annemans, PhD; Ghent University; Ghent, Belgium
  • Francis Arickx, PharmD; National Institute for Health and Disability Insurance RIZIV INAMI, Brussels, Belgium
  • Andrzej Rys, MD; European Commission; Brussels, Belgium
  • Catherine Smallwood, DPhil, MSc; World Health Organization Europe; Copenhagen Area, Denmark

Plenary 3: Broader Value Assessments for Special Populations and Technologies- Are We Closing a Gap or Widening a Divide?
Friday, 3 December 2021
This closing plenary session will consider the emerging needs and new frontiers in broader value assessment, including what is needed from key stakeholders to generate the willingness, ability, and evidence for broader value assessment of special technologies in special populations. Speakers include:

  • Moderator: Lotte Steuten, PhD; Office of Health Economics, University of London; London, England, UK
  • Annie Hubert; ESAH Biopharma Consulting; Brussels, Belgium
  • Gillian Leng; NICE; London, England, UK
  • Peter Neumann, ScD; Tufts Medical Center; Boston, MA, USA
  • Ben Osborn; Pfizer; Tadworth, England, UK
  • Avril Daly, Retina International, Zürich Switzerland

ISPOR members have been instrumental in addressing the pandemic through COVID-19 research. HEOR provides the scientific community with important evidence to respond to the pandemic and help the world to move forward in the face of the many challenges posed by COVID-19. ISPOR’s members and chapters around the globe have been called on to advise health ministries, health technology assessment organizations, and decision-making bodies within local, national, and regional governments around the world on the COVID 19 recovery.

ISPOR is recognized globally as the leading professional society for health economics and outcomes research and for its role in improving healthcare decisions. Virtual ISPOR Europe 2021 will draw healthcare stakeholders with an interest in HEOR, including researchers and academicians, assessors and regulators, payers and policymakers, the life sciences industry, healthcare providers, and patient engagement organizations.

Additional information on the conference can be found at:
Conference Information | Program | Press | Exhibits & Sponsorship


ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram

Related Stories

ISPOR Europe 2023 Plenaries and Speakers Announced

Sep 25, 2023

ISPOR announced the plenary sessions and speakers for ISPOR Europe 2023. The conference is scheduled for 12-15 November in Copenhagen, Denmark with the theme, “Health Economics and Outcomes Research at the Nexus of Policy and Science.”

ISPOR Announces Real-World Evidence Summit 2023

Apr 18, 2023

ISPOR announced its ISPOR Real-World Evidence Summit 2023 scheduled for May 7 in Boston, MA, USA. The Summit is collocated with and being held immediately prior to the Society’s annual international conference, ISPOR 2023.

ISPOR 2023 Plenaries and Speakers Announced

Apr 17, 2023

ISPOR announced the plenary sessions and speakers for its annual international conference, ISPOR 2023. The conference is scheduled for May 7-10 in Boston, MA, USA with the theme, “Impacting Innovation, Value, and Healthcare Decision Making.”
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now